Slide News & Events

Press Releases

February 3, 2022

14 Growing Massachusetts Firms Named Winners of Team Massachusetts "IMPACT" Awards

Watertown, MA – MassEcon, the state’s private sector partner in promoting business growth in Massachusetts, today announced its Eighteenth Annual Team Massachusetts Economic Impact Award winners, recognizing 14 companies for their outstanding contributions to the Massachusetts economy. The companies were selected for establishing new operations in Massachusetts or expanded existing operations…

February 2, 2022

Lykan Bioscience Welcomes Jay Blackington as Head of People and Culture

Hopkinton, MA — Lykan Bioscience, an innovative contract development and manufacturing organization (CDMO) focused on cell-based therapies, today welcomes Jay Blackington as Head of People and Culture. Jay joins the executive leadership team and will be responsible for establishing Lykan’s strategic human resources direction and leading the People and Culture organization…

November 9, 2021

Lykan Bioscience to Expand its Cell Therapy Clinical and Commercial Manufacturing Capacity by 90% and Add Innovation Laboratory

Hopkinton, MA – Lykan Bioscience, an innovative contract development and manufacturing organization (CDMO) focused on cell-based therapies, today announced plans to expand its state-of the art, purpose-built facility in Hopkinton, MA. The expansion is driven by the significant and growing demand for cell therapy process development and manufacturing…

September 30, 2021

MassEcon Announces Finalists for 18th Annual Economic Impact Awards

Watertown, MA – Fourteen companies from across the state have been selected as finalists for the 2021 Team Massachusetts Economic Impact Awards, MassEcon’s annual celebration of firms for their outstanding contributions to the Massachusetts economy…

August 12, 2021

Lykan Bioscience Partners with Vineti to Advance Cell-based Therapies from Clinical to Commercialization

Hopkinton, MA and San Francisco, CA — Lykan Bioscience, a contract development and manufacturing organization (CDMO) focused on cell-based therapies, and Vineti, the world’s only enterprise software platform supporting supply chain orchestration for clinical and commercial cell therapies…

April 13, 2021

Lykan Bioscience Welcomes Kenneth LeClair as Chief Technology Officer

Hopkinton, MA — Lykan Bioscience, a contract development and manufacturing services organization and provider of the first true end-to-end solution for the manufacture of cell-based therapies…

April 1, 2021

Lykan Bioscience Appoints Industry Leader Patrick Lucy as President & CEO

Hopkinton, MA — Lykan Bioscience, a contract development and manufacturing services organization and provider of the first true end-to-end solution for the manufacture of…

February 15, 2021

Lykan Bioscience Welcomes Keith McCormick as Chief Financial Officer

Lykan Bioscience, a contract Manufacturing Services OrganizationTM (MSO) and provider of the first true end-to-end solution for the manufacture of cell- based therapies, welcomes Keith McCormick…

January 4, 2021

Lykan Bioscience Welcomes Patrick Lucy as President and Chief Operating Officer

Lykan Bioscience, a contract Manufacturing Services OrganizationTM (MSO) and provider of the first true end-to-end solution for cell-based therapies, welcomes Patrick Lucy as President and Chief…

October 27, 2020

Senate President Karen Spilka Nominates Lykan Bioscience for Manufacturer of the Year

On October 14, 2020, Massachusetts State Senate President Karen E. Spilka nominated Hopkinton-based Lykan Bioscience for a ‘Manufacturer of the Year’ award, part of a series of awards…

September 17, 2020

Lykan Bioscience Announces Opening of SMART Manufacturing™ Facility at Ribbon Cutting Event in Hopkinton, MA

At its ribbon cutting celebration, Lykan Bioscience, a cell-based therapies contract Manufacturing Services Organization (MSO) is pleased to announce the grand opening of our 64,000 square…

Conferences & Events

January 25-28, 2022

2022 BIO International Convention

The BIO International Convention attracts thousands of biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships.